This content is restricted to site members. If you are an existing user, please log in. New users may register below.
CROMA-PHARMA COMPLETED THE DECENTRALIZED PROCEDURE FOR ITS BOTULINUM TOXIN TO TREAT GLABELLAR (FROWN) LINES
Croma-Pharma (Croma) announced that the decentralized procedure for its botulinum toxin to gain market authorization in Europe has been accomplished. This important step is the basis to complete Croma’s already